Dynavax Technologies | Cassa E Equivalenti



Cash And Equivalent Cambiamento Data
AbbVie USD 5.18B 349M 2025-03
Adma Biologics USD 103.15M 16.44M 2024-12
Amgen USD 8.03B 782M 2025-06
AstraZeneca USD 7.06B 1.83B 2025-06
Biogen USD 2.76B 160.5M 2025-06
BioMarin Pharmaceutical USD 1.21B 601.78M 2025-06
Bristol-Myers Squibb USD 12.6B 1.72B 2025-06
Dynavax Technologies USD 99.1M 562.24M 2025-06
Gilead Sciences USD 5.14B 2.78B 2025-06
Glaxosmithkline GBP 3.87B 678M 2024-12
Merck USD 8.01B 622M 2025-06
Neurocrine Biosciences USD 264M 69.9M 2025-06
Novartis USD 6.66B 410M 2025-06
Pfizer USD 1.64B 208M 2025-06
Regeneron Pharmaceuticals USD 2B 1.09B 2025-06
Roche Holding CHF 6.98B 2.15B 2024-12
Sarepta Therapeutics USD 510.6M 269.73M 2025-06
TG Therapeutics USD 278.86M 146.72M 2025-06
Vertex Pharmaceuticals USD 6.38B 1.71B 2025-06


Dynavax Technologies Cassa E Equivalenti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.